Join Eric Lenze, AB ’90, MD ’94, HS ’98, head of the Department of Psychiatry, for a reception and presentation in San Francisco on longevity and brain health.
📅Tuesday, May 19
⏰6-8 p.m. PST
📍La Mar, San Francisco; PIER 1 1/2 The Embarcadero N, San Francisco, CA 94111
Guests can enjoy complimentary drinks and hors d’oeuvres while learn how how WashU researchers are leading the way in developing interventions that improve both brain health and longevity, and connect with the Bay Area WashU Medicine community.
Free to attend but registration is required.
Questions? Contact us at medicaladvancement@wustl.edu or call 314-935-2728.
BRAIN HEALTH AND LONGEVITY: LIVING WELL
Brain health determines how we think, feel, connect, and maintain purpose throughout life. As humans live longer, advances in science are revealing that our brain health can be protected, strengthened, and even restored. At the same time, conditions like depression and anxiety are increasingly recognized as major, but treatable, barriers to both brain health and longevity.
Dr. Eric Lenze, Professor and Head of Psychiatry at WashU Medicine, will share practical insights into maintaining brain health as we age, and highlight how WashU researchers are leading the way in developing interventions that improve both brain health and longevity—offering new hope for healthier, longer lives.
ABOUT ERIC LENZE, MD
Dr. Lenze is the Wallace & Lucille Renard Professor of Psychiatry, the Director of the Healthy Mind Lab, and Chair of the Department of Psychiatry at Washington University School of Medicine in St. Louis, Missouri.
Dr. Lenze is a clinical trialist who has successfully advanced evidence-based medicine for depression, anxiety, and cognitive disorders in older adults. In a series of successful and ongoing clinical trials, he has tested the benefits and risks of antidepressants, deprescribing, mindfulness, cognitive behavioral therapy, and exercise.
Dr. Lenze has also advanced the concept of the Precision Clinical Trial, a framework for using clinical trials to advance precision medicine in neurobehavioral disorders.